August 31, 2016 12:47 AM ET


Company Overview of Tanox Inc.

Company Overview

As of August 2, 2007, Tanox, Inc. was acquired by Genentech, Inc. Tanox, Inc., a biotechnology company, engages in the discovery and development of therapeutic monoclonal antibodies for the treatment of immune-mediated diseases, infectious diseases, inflammation, and cancer in the United States. It markets Xolair, an anti-IgE antibody for the treatment of adults and adolescents with moderate-to-severe persistent asthma. The company is also developing TNX-355 for the treatment of HIV/AIDS that completed a Phase 2 clinical trial; and TNX-650, a humanized anti-IL-13 antibody for the treatment of Hodgkin’s lymphoma in patients who are refractory to chemotherapy or radiation treatment, which is i...

10301 Stella Link

Houston, TX 77025

United States

Founded in 1986

197 Employees





Key Executives for Tanox Inc.

Tanox Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tanox Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at